Raphael Pharmaceutical Inc.
RAPH· OTC
RAPHRaphael Pharmaceutical Inc.
Filed Mar 31, 2026 · 10-K · 90 days after period end · 0001213900-26-037402
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$273.00K | -$395.00K | $122.00K | -$1.10M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Raphael Pharmaceutical Inc. · CIK 1415397 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end
